| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | XOM | United States | $144.28 | $332,238,000,000.00 | Buy | 25 | 2005 |
#2 | JNJ | United States | $221.58 | $0.00 | Buy | 20 | 2003 |
#3 | CVX | United States | $181.21 | $189,031,000,000.00 | Buy | 20 | 1994 |
#4 | SHEL | United Kingdom | $83.96 | $0.00 | Buy | 10 | N/A |
#5 | WFC | United States | $75.80 | $0.00 | Buy | 18 | N/A |
#6 | MCD | United States | $275.00 | $26,885,000,000.00 | Buy | 29 | 1996 |
#7 | APH | United States | $128.14 | $0.00 | Strong Buy | 12 | 1994 |
#8 | ABT | United States | $84.22 | $44,328,000,000.00 | Strong Buy | 20 | 2006 |
#9 | TJX | United States | $153.54 | $29,078,407,000.00 | Strong Buy | 16 | 1994 |
#10 | ANET | United States | $141.39 | $9,005,700,000.00 | Strong Buy | 17 | 2014 |
#11 | SCHW | United States | $88.38 | $0.00 | Buy | 18 | N/A |
#12 | PFE | United States | $25.72 | $62,579,000,000.00 | Buy | 14 | 2013 |
#13 | COP | United States | $114.06 | $58,944,000,000.00 | Buy | 23 | 2005 |
#14 | MDT | Ireland | $75.96 | $33,537,000,000.00 | Buy | 21 | 2014 |
#15 | CB | Switzerland | $319.19 | $59,402,000,000.00 | Buy | 21 | 1995 |
#16 | DHR | United States | $171.24 | $19,893,000,000.00 | Strong Buy | 13 | 2006 |
#17 | PH | United States | $876.22 | $14,302,392,000.00 | Buy | 21 | 2001 |
#18 | SYK | United States | $285.72 | $25,116,000,000.00 | Buy | 14 | 1994 |
#19 | SNY | France | $43.25 | $0.00 | Buy | 5 | N/A |
#20 | MCK | United States | $735.22 | $112,084,000,000.00 | Strong Buy | 14 | 1995 |
#21 | NOC | United States | $549.06 | $41,954,000,000.00 | Buy | 16 | 2002 |
#22 | DUK | United States | $124.22 | $0.00 | Buy | 16 | N/A |
#23 | WM | United States | $215.30 | $14,485,000,000.00 | Buy | 20 | 2002 |
#24 | MSI | United States | $384.04 | $6,380,000,000.00 | Strong Buy | 7 | 1994 |
#25 | COR | United States | $260.93 | $321,332,819,000.00 | Buy | 14 | 2001 |
#26 | SRE | United States | $91.86 | $0.00 | Buy | 14 | N/A |
#27 | LHX | United States | $299.73 | $6,182,000,000.00 | Buy | 10 | 2001 |
#28 | CVNA | United States | $77.57 | $20,322,000,000.00 | Buy | 24 | 2017 |
#29 | VST | United States | $147.19 | $17,738,000,000.00 | Buy | 11 | 2016 |
#30 | ZTS | United States | $82.89 | $9,467,000,000.00 | Buy | 12 | 2012 |
#31 | CAH | United States | $184.12 | $222,578,000,000.00 | Buy | 12 | 1994 |
#32 | YUM | United States | $152.05 | $8,214,000,000.00 | Buy | 17 | 1997 |
#33 | PEG | United States | $77.18 | $12,168,000,000.00 | Buy | 12 | 1994 |
#34 | MDLN | United States | $39.76 | $0.00 | Strong Buy | 23 | N/A |
#35 | ALC | Switzerland | $62.71 | $0.00 | Buy | 12 | 2002 |
#36 | PCG | United States | $16.19 | $0.00 | Buy | 8 | N/A |
#37 | RBLX | United States | $41.81 | $2,225,052,000.00 | Buy | 24 | 2020 |
#38 | DVN | United States | $45.66 | $17,188,000,000.00 | Buy | 21 | 1999 |
#39 | INSM | United States | $101.14 | $0.00 | Strong Buy | 24 | 2000 |
#40 | FE | United States | $44.42 | $15,090,000,000.00 | Buy | 14 | 2005 |
#41 | NRG | United States | $138.55 | $30,713,000,000.00 | Strong Buy | 13 | 1997 |
#42 | CNP | United States | $41.77 | $9,357,000,000.00 | Buy | 13 | 2001 |
#43 | MTD | Switzerland | $1,119.47 | $4,026,399,000.00 | Buy | 12 | 1997 |
#44 | PPL | United States | $35.80 | $9,042,000,000.00 | Buy | 13 | 2007 |
#45 | TPR | United States | $133.08 | $5,880,000,000.00 | Buy | 17 | 2000 |
#46 | CMS | United States | $72.78 | $0.00 | Buy | 11 | N/A |
#47 | FN | Cayman Islands | $618.81 | $3,419,327,000.00 | Buy | 8 | 2007 |
#48 | WTW | United Kingdom | $255.90 | $9,708,000,000.00 | Buy | 14 | 2006 |
#49 | DGX | United States | $187.54 | $11,035,000,000.00 | Buy | 13 | 1996 |
#50 | STE | United States | $207.49 | $5,459,515,000.00 | Buy | 5 | 2018 |
The FinQuota filters have identified what they believe to be the "Best Undervalued Blue Chip Stocks (May 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.